Day Trader’s Aftermarket Lounge 4 Aug 2020, page-76

MESO also having a good night on the nasdaq. Several days of 5% or greater rises have made MSB tradable and great ST hold. A lot of announcements to come from various treatments against significant issues on phase 3 trial. The real excitement is the potential for stem cells to be used for these treatments (a significant medical leap) and stem cells to be used regularly in place of animal or similar models/trials.

I'm context there are CV19 stem cell models to understand the virus longer term impacts underway in Aus and overseas. MSB are completing a Phase 3 trial to evaluate stem cell treatments, which in a small sample size administered under compassionate circumstances in NY offered life saving results.

It looks like methodology to produce larger and cheaper quantities of these treatments are developing.